MARIA PIANTANIDA: Open Payments
NPI 1023737855 · SHREWSBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,252 in 148 payments from 10 companies in 2025. Trend: 2023 $865 · 2024 $1,868 · 2025 $2,252
Food & beverage: $2,252
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $548 |
| ABBVIE INC. | 49 | $485 |
| Otsuka America Pharmaceutical, Inc. | 22 | $351 |
| Axsome Therapeutics, Inc. | 15 | $310 |
| Teva Pharmaceuticals USA, Inc. | 13 | $196 |
| Lundbeck LLC | 16 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Alkermes, Inc. | 4 | $70 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Corium, LLC | 1 | $16 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Auvelity, AUSTEDO XR, TRINTELLIX, LYBALVI, ARISTADA.
Industry payments across NJ — which companies pay providers there.
